<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03555630</url>
  </required_header>
  <id_info>
    <org_study_id>[1167446</org_study_id>
    <nct_id>NCT03555630</nct_id>
  </id_info>
  <brief_title>Thromboelastogram in Postdelivery Preeclamptic Patients</brief_title>
  <official_title>Effect of Age on Reference Values for Thromboelastography in Pregnant Women With Pre-eclampsia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Augusta University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Augusta University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      There are no studies evaluating the effect of aging on hemostasis of preeclamptic patients.
      Additionally, although there are some studies that establish normal reference values for TEG
      profiles in healthy term pregnant patients, conflicting results have been found in
      preeclampsia. Reference values are important to establish baseline parameters in cases of
      pre-eclampsia complicated by postpartum hemorrhage. The investigators will evaluate reference
      values for TEG in postdelivery preeclamptic patients and the difference between vaginal
      delivery and cesarean section.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      After approval by the Institutional Review Board and informed consent from participants, the
      investigators are obtaining blood samples for TEG processing, from pregnant patients admitted
      to the maternity unit of Augusta University Medical Center. Patients are being classified in
      2 groups: term pregnant patients with diagnosis of pre-eclampsia who undergo cesarean section
      and those having spontaneous vaginal delivery. Each group will be divided into subgroups
      according to maternal age: 18-25 years, 26-35 years, &gt;36 years. Pre-eclampsia is defined and
      classified according to the definitions of the American College of Obstetricians and
      Gynecologists published in 2013.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 22, 2018</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">October 31, 2019</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>R time</measure>
    <time_frame>10 minutes</time_frame>
    <description>Reaction time of whole blood</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>K time</measure>
    <time_frame>10 minutes</time_frame>
    <description>Activation time</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum amplitude</measure>
    <time_frame>10 minutes</time_frame>
    <description>Amplitude in relation to platelet count and function</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>LY-30</measure>
    <time_frame>30 minutes</time_frame>
    <description>Lysis at 30 minutes</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">30</enrollment>
  <condition>Preeclampsia</condition>
  <condition>Coagulation Disorder</condition>
  <condition>Pregnancy Complications</condition>
  <arm_group>
    <arm_group_label>Post-cesarean preeclampsia</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Post spontaneous vaginal delivery preeclampsia</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Thromboelastogram</intervention_name>
    <description>Blood sample processing for thromboelastogram</description>
    <arm_group_label>Post spontaneous vaginal delivery preeclampsia</arm_group_label>
    <arm_group_label>Post-cesarean preeclampsia</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Term pregnant patients with preeclampsia
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years Mental competence Gestational age &gt; 37-week Informed consent Diagnosis
             of preeclampsia (with or without features of severity)

        Exclusion Criteria:

        Gestational age &lt; 37-week Known bleeding or thrombotic diathesis Use of aspirin or
        unfractionated or low-molecular weight heparin within the last 48 hours BMI &gt; 35 Maternal
        comorbid conditions other than preeclampsia
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Pregnant patients</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Augusta University</name>
      <address>
        <city>Augusta</city>
        <state>Georgia</state>
        <zip>30912</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>June 1, 2018</study_first_submitted>
  <study_first_submitted_qc>June 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">June 13, 2018</study_first_posted>
  <last_update_submitted>March 23, 2020</last_update_submitted>
  <last_update_submitted_qc>March 23, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Augusta University</investigator_affiliation>
    <investigator_full_name>Efrain Riveros Perez, MD</investigator_full_name>
    <investigator_title>Assistant Professor Department of Anesthesiology and Perioperative Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Pregnancy Complications</mesh_term>
    <mesh_term>Hemostatic Disorders</mesh_term>
    <mesh_term>Blood Coagulation Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

